Loading

Journal of Addiction Medicine and Therapy

Attention Problems and Cognitive-Behavioural Therapy for Methamphetamine Users: Implications for Treatment

Review Article | Open Access

  • 1. Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Australia
  • 2. Peyman Opiate and Methamphetamine Use Treatment Clinic, Iran
+ Show More - Show Less
Corresponding Authors
Zahra Alam Mehrjerdi, Program of International Research and Training, National Drug and Alcohol Research Centre, Faculty of Public Health & Community Medicine, University of New South Wales, Sydney, NSW 2052, Australia, Tel +61 2 8936 1008; Fax +61 2 9385 0222
Abstract

Methamphetamine is a highly addictive psychostimulant drug with dramatic effects on attention. Impaired attention is a serious health concern among regular methamphetamine users especially when they are referred to cognitive-behavioural therapy. This review summarizes evidence that problems in different aspects of attention can significantly persist into abstinence and recovery. Continued problems in sustained attention, selective attention, focused attention, divided attention and alternating attention could result in treatment failure and returning to regular methamphetamine use. Impaired attention could prevent the effectiveness of cognitive-behavioural therapy which is the most common method to treat regular methamphetamine use. The continuity of attention problems especially in cognitive-behavioural therapy should be considered as a potential target for treatment. Rehabilitating attention including using environmental modification and support, attention process training, self-management strategies, orienting procedures, and psychosocial support may contribute to treating attention problems among regular methamphetamine users in cognitive-behavioural therapy. This issue may also increase treatment adherence and outcomes. No single technique of rehabilitation is universally accepted for treating attention problems in regular methamphetamine users but long-term attention rehabilitation is required in cognitive-behavioural therapy. Applying attention rehabilitation techniques could be associated with improved functioning in attention on a day-today basis as well as engagement of regular methamphetamine patients in cognitive-behavioural therapy. Attention rehabilitation techniques should be used as adjunct treatment services during implementing cognitive-behavioural therapy for regular methamphetamine users. Nonetheless, further studies on the effectiveness of the available attention rehabilitation techniques for regular methamphetamine users are still suggested.

Citation

Alam mehrjerdi Z, Kiakojouri A, Dolan K (2014) Attention Problems and Cognitive-Behavioural Therapy for Methamphetamine Users: Implications for Treatment. J Addict Med Ther 2(1): 1006

Keywords

•    Methamphetamine
•    Attention
•    Cognitive-behavioural therapy
•    Rehabilitation

INTRODUCTION

Methamphetamine

Methamphetamine is an addictive psychostimulant drug. Methamphetamine-associated problems constitute a critical public health concern in the world [1]. Methamphetamine is a synthetic derivative of amphetamine, but due to the addition of a methyl group in its chemical structure, it has relatively high lipid solubility, allowing more rapid transport of the drug across the blood-brain barrier [2]. The side effects of methamphetamine use are related to the dose and duration of methamphetamine use [3].

ATTENTION PROBLEMS IN REGULAR METHAMPHETAMINE USERS

Short-term methamphetamine use could increase attention for a short period of time. However, a number of studies have shown serious attention problems among regular methamphetamine users [4,2] which could persist for many years into abstinence and recovery. Attention is primarily a cognitive process that allows an individual to filter in or filter out environmental events [5]. Attention has some subcategories including sustained attention, selective attention, focused attention, divided attention and alternating attention. Selective attention is a cognitive function that facilitates the processing of relevant stimuli and inhibits less relevant stimuli. Selective attention increases the likelihood that most appropriate stimuli will control behavior [6-8].

Sustained attention refers to the ability to maintain a consistent behavioral response during continuous and repetitive activity. Selective attention refers to the ability to maintain a behavioural or cognitive set in the face of distracting or competing stimuli. Focused attention refers to the ability to respond discretely to specific stimuli. Divided attention involves the ability to respond simultaneously to multiple tasks and demands. Alternating attention refers to the capacity for mental flexibility that allows individuals to shift their focus of attention and move between tasks having different cognitive requirements, thus controlling which information will be selectively processed [9].

Many regular methamphetamine users find it difficult to continue performing tasks, even when no distraction exists. For a number of them, poor attention leads to fatigue. They realize that they make errors or have difficulty with a task that requires attention [9].

In addition, persistent attention problems negatively impact the communication skills and vocational opportunities of the newly recovered methamphetamine addicts. Smart and colleagues (1969) reported that regular methamphetamine users were the most likely of substance users to have an increased accident rate over the driving population [10].

PROLONGED ATTENTION PROBLEMS DURING ABSTINENCE

Using psychostimulant drugs, such as methamphetamine could result in significant problems in attention [11] which persists into abstinence [12]. Efforts to prevent methamphetamine use in abstinence could increase attention problems, hence intensifying methamphetamine users’ urge to relapse. This issue may contribute to methamphetamine users’ preoccupation with methamphetamine use and their lack of confidence in their ability to manage daily routine and achieving treatment success. The early stage of abstinence from regular methamphetamine use is an important period, because it is the time during which methamphetamine users experience deprivation from methamphetamine use [13]. This issue can lead to craving and problems in sustaining attention. In addition, the first weeks of abstinence from methamphetamine use is an important period for establishing engagement in treatment, and thus achieving positive treatment outcomes [13]. Nordahl and colleagues (2005) reported recovery with prolonged abstinence from methamphetamine use and this was positively correlated with duration of methamphetamine abstinence [14]. However, after two months of abstinence, methamphetamine-dependent patients were found to demonstrate serious problems in attention [15].

COGNITIVE-BEHAVIOURAL THERAPY

Several studies have shown that some cognitive problems correlate with clinical or treatment outcomes [16]. However, Gardini and colleagues (2009) showed that treatment could contribute to decreases in attention problems [17]. This issue also plays a significant role in enhancing treatment efficacy and positive treatment outcomes among regular methamphetamine users [18].

Psychosocial and behavioural approaches currently constitute the primary treatments for regular methamphetamine users [19]. There are no readily available substitution therapies for regular methamphetamine use. As a result, cognitive-behavioural therapy is considered the most approved method to address regular methamphetamine use. In general, Marlatt and Gordon (1985) introduced the concept of using cognitive-behavioural strategies in treating substance use disorders [20]. Cognitive-behavioural therapy includes a range of interventions such as cognitive restructuring and motivational interviewing which may be supplemented by strategies such as support groups [21, 22]. Cognitive-behavioural therapy modifies the client’s thinking, expectancies and behaviours and increases skills in coping with various stresses and barriers.

Brief interventions consisting of motivational interviewing and cognitive-behavioural therapy have been shown to increase the likelihood of abstinence from amphetamine use [23]. In addition, the Matrix Model, a manualised 16-week outpatient treatment approach for treating regular methamphetamine use, combines techniques and materials from the cognitive behavioural therapy to include accurate information on the effects of stimulants, family education, twelve-step program, and positive reinforcement for behaviour change and treatment compliance [24]. In general, the treatment response of regular methamphetamine users to cognitive behavioural therapy has been positive [24]. Recent reviews of controlled trials of psychosocial interventions have concluded that motivational interviewing and cognitive-behavioural therapy are primarily effective in treating regular amphetamine users [25, 26].

REHABILITATION OF ATTENTION PROBLEMS IN COGNITIVE-BEHAVIOURAL THERAPY

Cognitive-behavioural therapy cannot be successful if patients show a considerable number of attention problems. The cognitive problems decrease users’ cognitive sharpness [27] which in turn, reduces their ability to remain in treatment and this issue could predict later dropout. Attention problems especially during treatment could contribute to craving or relapse if they have not been treated, but study on effective rehabilitation for attention problem is scarce. Partial recovery of cognitive function following both short (i.e., two weeks) [28] and long (i.e., more than six months) [29] periods of abstinence can occur. Rehabilitating attention in cognitive-behavioural therapy can be followed by pharmacological interventions. For example, Ritalin can be prescribed for those methamphetamine patients who suffer from adult ADHD because Ritalin enhances focus and attention especially in activities such as driving [30].

Successful cognitive-behavioural therapy should be associated with reductions in problematic attention problems among regular methamphetamine users. In general, five approaches to address difficulties in attention have been proposed [8] which could be used for rehabilitating attention problems among regular methamphetamine users in cognitive-behavioural therapy. These approaches are as follows:

Environmental modifications and supports

Environmental modifications and support include reducing distraction and increasing organization. The outcome of this approach includes improving content for cognitive processing. Establishing environmental supports requires planning and monitoring. Careful assessment of the context, having a plan for measuring success or lack of success, ensuring the patient and others involved in the modification, and allowing them to get familiar with using the supports are important for the effectiveness of this intervention [31,32].

Attention process training

Attention process training includes providing opportunities for stimulating a particular aspect of attention. Reducing cognitive exercises and generalization training are the components of attention process training. Treatment involves having clients engage in a series of repetitive drills or exercises that are designed to provide opportunities for practicing tasks with greater attentional demands. Studies show that repeated activation and stimulation of attentional systems increase changes in cognitive capacity [33,7]. There are some attention training packages available for use. One example is the Attention Process Training program (APT) [7, 34]. APT is widely used to rehabilitate attention problems in people with brain injury but it may be used for rehabilitating attention problems in regular methamphetamine users in cognitive-behavioural therapy.

Self-management strategies

Self-management strategies could be used in conjunction with attention process training for regular methamphetamine users in cognitive-behavioural therapy. Self-management strategies include reducing, orienting, pacing, and key ideas. They involve self-instructional routines that help a client focus attention on a task. The outcome of this approach includes increased sense of self-control, and personal empowerment to focus on different attention-related works [35].

Orienting procedures

Orienting procedures could be used in increasing sustaining attention or screening out distractions. Orienting procedures encourage an individual to consciously monitor his/her activities, thereby avoiding attentional lapses. Teaching clients to ask themselves orienting questions at a specified time is an example of implementing orienting procedures. Clients with attention problems generally report fatigue or problem in maintaining concentration over an extended period of time, therefore teaching pacing strategies may be helpful. Pacing allows clients to continue for a longer period of time. Involving the client and relevant key persons in the design and piloting of a pacing strategy are important in ensuring that it is well-utilized. Another attention problem that interferes with day-to-day functioning is difficulty in switching between tasks. A common complaint is that individuals cannot resume an activity if they are interrupted or temporarily divert their attention. To manage this difficulty, individuals learn to rapidly jot key questions or ideas that come to mind that need to be addressed later on. This allows them to continue with a particular task. There are a number of external devices and aids that assist individuals in tracking information and initiating planned activities such as written calendar systems with day planners, task-specific devices and checklists [35].

Psychosocial support

The importance of psychosocial support for managing attention problems cannot be underestimated. Effective management of attention problems requires a clinician to be skilled at providing psychosocial support as well as cognitive intervention. Decreased attention is important to acknowledge the interaction between cognitive dysfunction and psycho-emotional difficulties when designing a rehabilitation program for rehabilitating attention problems. Helping clients track the contexts where their attention processes break down, as well as situations where their attention is functioning well, generally results in a perception that attention is improving [35].

DISCUSSION

Regular methamphetamine use leads to serious problems in inhibition and filtering out irrelevant information upon acute administration [36]. Regular methamphetamine use also results in decreases in ability to filter information [36].

Cognitive impairments reported in regular methamphetamine users have the potential to compromise their ability to engage in, and benefit from cognitive-behavioural therapy, arguably the most effective treatment [37]. Considering its highly addictive potential, regular methamphetamine use leads to adverse psychosocial and behavioral outcomes. Regular methamphetamine use generally results in irritability, agitation, poor coping skills and disorganized lifestyles [38,39]. Impulsive behavior may exacerbate their psychosocial difficulties and promote maintenance of drug-seeking behavior, and this impulsivity and lack of adequate attention may be greater in those who use large amounts of methamphetamine [40]. These issues are followed with clinical observations that show methamphetamine users are distractible and have difficulty in maintaining attention [4]. Findings from this review suggest that regular methamphetamine users show critical attention problems which could persist into abstinence and recovery [2,4].

In addition, attention problems among regular methamphetamine users could increasingly impair their procedure of cognitive-behavioural therapy [9]. Studies show that people with brain injury show serious attention problems which can be treated with some approved attention rehabilitation techniques. Alternatively, these people may experience more in control when they are assisted to pay attention to their own functioning in everyday life [35].

Rehabilitating attention include using environmental modification and support, attention process training, self-management strategies, orienting procedures, and psychosocial support. There is a growing literature suggesting they can be effective in people diagnosed with brain injury and other disorders. For example, in their study on brain damaged patients, Sturm and colleagues (1993) showed the effectiveness of attention training in increasing attention [41].

Sivak and colleagues (1984) reported improved driving performance following perceptual skills and attention training in a group of individuals with brain damage [42]. The attention rehabilitation techniques could also be used for regular methamphetamine users in cognitive-behavioural therapy. No single technique of rehabilitation is universally accepted for treating attention problems in regular methamphetamine users but long-term attention rehabilitation is required for many months during cognitive-behavioural interventions [9].

It should be noted that certain cognitive-behavioural interventions including the Matrix Model and brief interventions have been mainly used to treat regular methamphetamine users [43, 23]. Cognitive-behavioural interventions cannot be solely successful while attention rehabilitation techniques are not simultaneously applied. Applying attention rehabilitation techniques may be associated with improved functioning in attention on a day-today basis as well as engagement of regular methamphetamine patients in cognitive-behavioural therapy.

As an adjunct treatment service, clinicians can apply these approaches to rehabilitate attention problems in regular methamphetamine users during implementing cognitive-behavioural therapy but the effectiveness of these approaches in reducing attention problems should be studied. It should be noted that the measurement of improvement at the level of everyday functioning is the most important indicator of success or failure of attention rehabilitation techniques [9].

The reason for the current focus on attention problems in this review is that these problems fuel the motivation to use methamphetamine in cognitive-behavioural therapy and can eventuate actual use of it and as a result, poor treatment outcomes. In addition, attention problems are undesirable for abstainers because of mood disturbances and interference with thought processes and daily activities [44].

The prolonged attention problems of regular methamphetamine users suggest that cognitive-behavioural therapy should be partly allocated to rehabilitate attention problems. This issue could act as an important facilitating factor in increasing patients’ engagement in cognitive-behavioural therapy and enhancing treatment efficacy.

The understanding of how attention problems recover as a function of prolonged methamphetamine abstinence in cognitive-behavioral interventions has important clinical and treatment implications. If improvement in attention occurs across prolonged periods of abstinence, this finding would be clinically important for psychotherapists. These cognitive improvements can then be applied in cognitive-behavioural therapy and can be utilized as predictors of treatment effectiveness in difficult patients [45]. Such information could also contribute to optimizing the timing of cognitively demanding interventions. Hard efforts to design novel rehabilitation techniques to manage attention may contribute to emerging new treatment options to improve attention problems in regular methamphetamine users.

REFERENCES

1. Maxwell JC. Emerging research on methamphetamine. Curr Opin Psychiatry. 2005; 18: 235-242.

2. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci. 2006; 31: 301-313.

3. Rau KS, Birdsall E, Volz TJ, Riordan JA, Baucum AJ 2nd, Adair BP, et al. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake. J Pharmacol Exp Ther. 2006; 318: 676-682.

4. Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci. 2003; 15: 317-325.

5. MacLeod CM, MacDonald PA. Interdimensional interference in the Stroop effect: uncovering the cognitive and neural anatomy of attention. Trends Cogn Sci. 2000; 4: 383-391.

6. Holland PC, Gallagher M. Amygdala circuitry in attentional and representational processes. Trends Cogn Sci. 1999; 3: 65-73.

7. Sohlberg MM, Mateer CA. Effectiveness of an attention-training program. J Clin Exp Neuropsychol. 1987; 9: 117-130.

8. Sohlberg MM. Mateer CA. Cognitive rehabilitation: Introduction to theory and practice. Guilford Press. New York; 1989.

9. Alam mehrjerdi Z, Noroozi A, Barr AM, Ekhtiari H. Attention deficits in chronic methamphetamine users as a potential target for enhancing treatment efficacy. Iran J Bas Clin Neurosci. 2012; 3: 5-14.

10. Smart RG, Schmidt W, Bateman K. Psychoactive drugs and traffic accidents. J Safety Res. 1969; 1: 67-73.

11. Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology. 2000; 54: 1344-1349.

12. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005; 58: 770-778.

13. Brecht ML, von Mayrhauser C, Anglin MD. Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs. 2000; 32: 211-220.

14. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, et al. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2005; 62: 444- 452.

15. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res. 2002; 111: 65-74.

16. Leber WR, Parsons OA, Nichols N. Neuropsychological test results are related to ratings of men alcoholics’ therapeutic progress: a replicated study. J Stud Alcohol. 1985; 46: 116-121.

17. Gardini S, Caffarra P, Venneri A. Decreased drug cue-induced attentional bias in individuals with treated and untreated drug dependence. Acta Neuropsychiatr. 2009; 21:179-185.

18. Sadek JR, Vigil O, Grant I, Heaton RK; HNRC Group. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol. 2007; 29: 266-276.

19. Rawson RA, Anglin MD, Ling W. Will the methamphetamine problem go away? J Addict Dis. 2002; 21: 5-19.

20. Marlatt A, Gordon R. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press; 1985.

21. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 1994; 51: 568-576

22. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry. 1993; 150: 763-769.

23. Baker A1, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction. 2005; 100: 367-378.

24. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004; 99: 708-717.

25. Baker A, Lee NK. A review of psychosocial interventions for amphetamine use. Drug Alcohol Rev. 2003; 22: 323-335.

26. Baker A, Gowing L, Lee NK, Proudfoot H. Psychosocial interventions. In: Baker A, Lee NK, Jenner L, eds. Models of Intervention and Care for Psychostimulant Users, 2nd edn. National Drug Strategy. Canberra: Australian Government Department of Health and Ageing; 2004; 51: 63-84.

27. Stormark KM, Laberg JC, Nordby H, Hugdahl K. Alcoholics’ selective attention to alcohol stimuli: automated processing? J Stud Alcohol. 2000; 61: 18-23.

28. Chou YH, Huang WS, Su TP, Lu RB, Wan FJ, Fu YK. Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study. Eur Neuropsychopharmacol. 2007; 17: 46-52.

29. Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, et al. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry. 2004; 161: 242-248.

30. Jerome L, Segal A. Benefit of long-term stimulants on driving in adults with ADHD. J Nerv Ment Dis. 2001; 189: 63-64.

31. Mateer CA. Rehabilitation of individuals with frontal lobe impairment. In Neuropsychological Rehabilitation and Treatment of Brain Injury. G.R. Press. Orlando, FL; 1997.

32. Sohlberg MM. Psychotherapy in individuals with mild neurologic dysfunction. In neuropsychological management of mild traumatic brain injury, pp. 137-156. Oxford University Press. London/New York; 2000.

33. Park N, Proulx GB, Towers WM. Evaluation of the Attention Process Training programme. J Neuropsychol Rehabil. 1999; 9: 135-154.

34. Sohlberg MM, Johnson L, Paule L, Raskin SA, Mateer CA. Attention Process Training II: A Program to Address Attentional Deficits for Persons with Mild Cognitive Dysfunction [Rehabilitation Materials]. Association for Neuropsychological Research and Development. Puyallup, WA; 1994.

35. Sohlberg MM, Glang A, Todis B. Improvement during baseline: three case studies encouraging collaborative research when evaluating caregiver training. Brain Inj. 1998; 12: 333-346.

36. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev. 2007; 17: 275-297.

37. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex. 2001; 41: 17-35.

38. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA. Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat. 2003; 24: 267-277.

39. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex. 2001; 41: 17-35.

40. Semple SJ, Zians J, Grant I, Patterson TL. Impulsivity and methamphetamine use. J Subst Abuse Treat. 2005; 29: 85-93.

41. Sturm W, Hartje W, Orgass B, Wiliams, K. Computer-assisted rehabilitation of attention impairments. In developments in the assessment of rehabilitation of braindamaged patients. Narr. Tübingen, Germany; 1993.

42. Sivak M, Hill CS, Olson PL. Computerized video tasks as training techniques for driving-related perceptual deficits of persons with brain damage: a pilot evaluation. Int J Rehabil Res. 1984; 7: 389-398.

43. Anglin D, Rawson, R. (Eds.) The CSAT methamphetamine treatment project: Moving research into the “real world.” J Psychoact Drugs. 2000; 32: 135-136.

44. Bradley MM, Codispoti M, Cuthbert BN, Lang PJ. Emotion and motivation I: defensive and appetitive reactions in picture processing. Emotion. 2001; 1: 276-298.

45. Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008; 33: 827-836.

Alam mehrjerdi Z, Kiakojouri A, Dolan K (2014) Attention Problems and Cognitive-Behavioural Therapy for Methamphetamine Users: Implications for Treatment. J Addict Med Ther 2(1): 1006.

Received : 02 Jan 2014
Accepted : 28 Feb 2014
Published : 28 Feb 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X